Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection

NCT02141373 is registered in ClinicalTrials.gov with King Hussein Cancer Center as lead sponsor.

NCT NCT02141373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02141373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection
Lead sponsor
King Hussein Cancer Center
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2013
Completion date
Not reported
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer